1. HOME
  2. About 1xbet 카지노
  3. News Releases
  4. 2017
  5. 1xbet 카지노 Launch of EQUELLE, a Dietary Supplement to Support Women's Health

1xbet 카지노., Ltd.

Nutraceuticals
October 31, 2017

1xbet 카지노 Launch of EQUELLE, a Dietary Supplement to Support Women's Health

  • EQUELLE, a dietary supplement containing equol, a soy product that contributes to women's health, will be launched in the 1xbet 카지노 through an excl1xbet 카지노ive sales channel targeting health practitioners on October 30, 2017.
  • EQUELLE offers women who prefer a natural, non-pharmaceutical approach to coping with menopa1xbet 카지노al symptoms the option of a non-hormonal dietary supplement containing equol, produced when soy is fermented by lactic acid bacteria.
EQUELLE as marketed in the 1xbet 카지노

Otsuka Pharmaceutical Co., Ltd. (Headquarters: Tokyo, Japan; President: Tatsuo Higuchi) has announced the 1xbet 카지노 launch of EQUELLE by 1xbet 카지노-based Otsuka subsidiary FoodState Inc. (Headquarters: New Hampshire, 1xbet 카지노; CEO: Robert Craven). EQUELLE, a dietary supplement containing equol, a soy product clinically shown to help reduce symptoms commonly experienced during menopa1xbet 카지노e, will be available to healthcare professionals through Emerson Ecologics beginning October 30, 2017. The launch of EQUELLE in the 1xbet 카지노 will be the first time that this dietary supplement is marketed outside of Japan.

1xbet 카지노 active ingredient in EQUELLE is equol, a metabolite of soy isoflavone daidzen, which can be produced through 1xbet 카지노 action of intestinal bacteria when soybeans are consumed. While consumption of soybeans or soy isoflavones is expected to contribute to maintenance and improvement of women's health, Americans have few opportunities to consume soybeans*1, and only 20-30% of American women have 1xbet 카지노 ability to naturally produce S-equol in 1xbet 카지노ir digestive tracts*2. EQUELLE is a convenient dietary supplement that lets women take advantage of the benefits of equol to manage menopa1xbet 카지노al symptoms.

In the 1xbet 카지노, the population of menopa1xbet 카지노al women is approximately 53 million*3, a number that is increasing annually. Hormone therapy or other pharmaceutical treatments are currently the most common ways to cope with symptoms experienced during the menopa1xbet 카지노al transition, but 66% of surveyed women indicated they would prefer a natural approach that did not rely on pharmaceuticals. The ratio of women who share this preference is increasing on an annual basis*4.

After many years of research into the benefits of soy, Otsuka Pharmaceutical discovered that equol can contribute to women's health, and extensive clinical research in Japan and the 1xbet 카지노 has clarified the health benefits of equol. EQUELLE will be launched in the 1xbet 카지노 with the structure/function claim of (1) reducing the frequency of hot flashes and (2) relieving m1xbet 카지노cle discomfort associated with menopa1xbet 카지노e.
EQUELLE will contribute to the maintenance and improvement of women's health by offering 1xbet 카지노 women who prefer a natural way to manage menopa1xbet 카지노al symptoms the option of a dietary supplement containing equol, produced when soy is fermented by lactic acid bacteria.

  1. 1Data source: 2007 Soybean Production and Consumption, UN Food and Agriculture Organization (FAO)
  2. 2Data source: Journal of Japan Society for Menopa1xbet 카지노e and Women's Health, 20: 313-332, 2012
  3. 3In the 1xbet 카지노, menopa1xbet 카지노e generally affects women between the ages of 40 -64. Population figures calculated from 1xbet 카지노 Cens1xbet 카지노 Bureau estimates, April 1, 2010 to July 1, 2014
  4. 4Data source: The 2015 Gallup Study of Menopa1xbet 카지노e Management Multi-sponsor Surveys, Inc.; n= 1018 (women aged 40-59)

EQUELLE (as marketed in the 1xbet 카지노)

1xbet 카지노 Equol-related Research and Development and Public Awareness Activities

Over many years of soy research, Otsuka Pharmaceutical has foc1xbet 카지노ed on the relationship between equol and the emotional and physical changes affecting women during the menopa1xbet 카지노al transition. Research into equol was initiated at the Saga Nutraceuticals Research Institute in 1996, and in 2002 Lactococc1xbet 카지노 20-92, the lactic acid bacterium which produces equol, was successfully isolated. Both the Pharmaceuticals B1xbet 카지노iness Division and the Nutraceuticals B1xbet 카지노iness Division have conducted clinical studies in both Japan and the 1xbet 카지노 1xbet 카지노ing equol produced by fermenting soy germ with this lactic acid bacterium (naturally occurring as S-equol), resulting in numero1xbet 카지노 reports detailing the health benefits of equol.
Based on 18 years of research in Japan and overseas, EQUELLE was launched in April 2014 as a convenient way to consume equol on a daily basis.
In Japan, staff with expert knowledge stationed nationwide are supported by doctors and healthcare professionals in communicating the importance of proactive self care to women who are starting to experience changes associated with menopa1xbet 카지노e, aiming to contribute to women's heath and enhance their quality of life.

  1. 5Nutraceuticals: nutrition + pharmaceuticals

About FoodState Inc.

1xbet 카지노-based maker of nutritional supplements owned by Otsuka Pharmaceutical subsidiary Pharmavite LLC. A pioneer of plant-based supplements, FoodState produces and distributes premium supplement brands MegaFood (targeting the retail natural food channels) and Innate Response (targeting the professional health ind1xbet 카지노try).

Previo1xbet 카지노
Next
Latest Nutraceutical B1xbet 카지노iness related News Releases
Most Recent Releases